"Prazosin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
| Descriptor ID |
D011224
|
| MeSH Number(s) |
D03.633.100.786.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prazosin".
Below are MeSH descriptors whose meaning is more specific than "Prazosin".
This graph shows the total number of publications written about "Prazosin" by people in this website by year, and whether "Prazosin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prazosin" by people in Profiles.
-
Clinical and polysomnographic features of trauma associated sleep disorder. J Clin Sleep Med. 2022 Dec 01; 18(12):2775-2784.
-
Lobeline attenuates progressive ratio breakpoint scores for intracranial self-stimulation in rats. Physiol Behav. 2008 Mar 18; 93(4-5):952-7.
-
The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia. Adv Ther. 1995 Nov-Dec; 12(6):361-6.
-
Alpha 1-adrenergic blockade and sudden cardiac death. J Cardiovasc Electrophysiol. 1994 Jan; 5(1):76-89.
-
A multicenter comparison of isradipine and prazosin for treatment of essential hypertension. Cardiovasc Drugs Ther. 1990 Apr; 4(2):413-7.